Transcend Capital Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.14M | Sell |
34,184
-28,306
| -45% | -$1.77M | 0.17% | 136 |
|
2025
Q1 | $3.76M | Sell |
62,490
-6,612
| -10% | -$398K | 0.27% | 88 |
|
2024
Q4 | $4.03M | Sell |
69,102
-2,378
| -3% | -$139K | 0.29% | 80 |
|
2024
Q3 | $4.23M | Sell |
71,480
-1,371
| -2% | -$81.2K | 0.28% | 83 |
|
2024
Q2 | $4.08M | Buy |
72,851
+267
| +0.4% | +$15K | 0.3% | 77 |
|
2024
Q1 | $4.25M | Buy |
72,584
+10,117
| +16% | +$593K | 0.34% | 69 |
|
2023
Q4 | $3.37M | Buy |
62,467
+14,522
| +30% | +$784K | 0.3% | 80 |
|
2023
Q3 | $2.33M | Buy |
+47,945
| New | +$2.33M | 0.23% | 101 |
|
2023
Q2 | – | Sell |
-4,202
| Closed | -$227K | – | 496 |
|
2023
Q1 | $227K | Sell |
4,202
-2,500
| -37% | -$135K | 0.02% | 421 |
|
2022
Q4 | $352K | Sell |
6,702
-3,520
| -34% | -$185K | 0.04% | 336 |
|
2022
Q3 | $482K | Sell |
10,222
-3,249
| -24% | -$153K | 0.05% | 285 |
|
2022
Q2 | $679K | Buy |
13,471
+545
| +4% | +$27.5K | 0.07% | 247 |
|
2022
Q1 | $788K | Sell |
12,926
-1,275
| -9% | -$77.7K | 0.07% | 248 |
|
2021
Q4 | $935K | Sell |
14,201
-126
| -0.9% | -$8.3K | 0.08% | 219 |
|
2021
Q3 | $932K | Buy |
14,327
+581
| +4% | +$37.8K | 0.08% | 218 |
|
2021
Q2 | $826K | Sell |
13,746
-5,130
| -27% | -$308K | 0.12% | 171 |
|
2021
Q1 | $1.04M | Sell |
18,876
-4,878
| -21% | -$269K | 0.13% | 173 |
|
2020
Q4 | $1.3M | Buy |
23,754
+2,928
| +14% | +$160K | 0.17% | 140 |
|
2020
Q3 | $1.04M | Buy |
+20,826
| New | +$1.04M | 0.19% | 110 |
|
2020
Q2 | – | Sell |
-36,816
| Closed | -$1.38M | – | 156 |
|
2020
Q1 | $1.38M | Buy |
+36,816
| New | +$1.38M | 0.41% | 73 |
|